Amesite (Nasdaq: AMST) Anticipates Sales Growth Amid Shifting Trade Dynamics
Amesite’s U.S. Workforce, Technology and Customers Insulate Company from Trade Uncertainties; Cost Concerns Drive Amesite Sales Growth
DETROIT, April 04, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today confirms that its operations remain unaffected by recently announced U.S. tariffs. Amesite is U.S.-owned with a fully remote, U.S.-based workforce and no reliance on foreign hardware or suppliers. Amesite’s cloud-native infrastructure avoids international chokepoints, shielding it from tariff impacts.
Software companies and platforms built on domestic technology and workforces remain insulated from the newly implemented trade policy, which sets a 10% tariff on most imports—and up to 32% on goods from certain countries.
Amesite CEO, Dr. Ann Marie Sastry, said, “Our sales trajectory reflects exactly what we anticipated. In a climate of rising uncertainty and costs, and increasing demand for care, solutions that deliver efficiency, accuracy, and scalability are even more essential. Powered by AI, NurseMagic™ reduces charting time by 95% and ensures audit-ready documentation—making our solution both high-performing and cost-effective for our customers.”
Brandon Owens, VP of Sales at Amesite, said, “Increasing cost pressures increase the demand for NurseMagic™. We’re strongly positioned to lead in the home health industry. Today, we’re onboarding larger organizations that are rolling out our platform enterprise-wide—across clinical and non-clinical teams, including social workers, administrators, and aides—fueling both user growth and revenue.”
About Amesite
Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $330 billion home and healthcare segments. Its flagship product, NurseMagicTM, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagicTM is used by over 100 professions to improve care, enhance operational efficiency and improve financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages.
Forward-Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations
